FinanceAsianet Newsable
Wells Fargo initiates coverage on five biotech stocks
in5points
Wells Fargo began coverage on five biotech stocks: CMPS, MDGL, DFTX, GHRS, HELP.
Only Compass Pathways received an 'Equal-Weight' rating from Wells Fargo.
The other four stocks received 'Overweight' ratings from Wells Fargo.
Wells Fargo believes next-wave depression drugs could create new winners.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically